Rockville, MD, United States of America

Zuzana Biesova

USPTO Granted Patents = 3 

Average Co-Inventor Count = 8.2

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Zuzana Biesova: Innovator in Vaccine Development

Introduction

Zuzana Biesova is a prominent inventor based in Rockville, MD (US), known for her significant contributions to the field of vaccine development. With a total of three patents to her name, she has made remarkable strides in creating immunogenic compositions that target various infectious diseases.

Latest Patents

One of her latest patents is focused on a multicomponent vaccine for malaria, which provides long-lasting immune responses against plasmodia. This patent discloses immunogenic conjugates that elicit an immune response to proteins, including sexual stage surface proteins and circumsporozoite protein (CSP). The patent also outlines immunogenic compositions that include these conjugates along with a pharmaceutically acceptable carrier. Another notable patent involves vaccines against the influenza virus, detailing immunogenic conjugates with a specific formula. This patent includes isolated immunogens that feature an immunogenic fragment of an influenza HA protein, modified for enhanced efficacy.

Career Highlights

Zuzana Biesova has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and New York University. Her experience in these institutions has allowed her to collaborate with leading experts in the field of immunology and vaccine research.

Collaborations

Throughout her career, Zuzana has collaborated with notable colleagues, including Rachel Schneerson and Joanna Kubler-Kielb. These partnerships have contributed to her innovative work in vaccine development and research.

Conclusion

Zuzana Biesova's contributions to vaccine innovation highlight her dedication to improving public health through scientific research. Her patents reflect her commitment to developing effective immunogenic solutions for infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…